Characterization of the cell-free DNA released by cultured cancer cells
- PMID: 26529550
- DOI: 10.1016/j.bbamcr.2015.10.022
Characterization of the cell-free DNA released by cultured cancer cells
Abstract
The most prominent factor that delays the translation of cell-free DNA (cfDNA) analyses to clinical practice is the lack of knowledge regarding its origin and composition. The elucidation of the former is complicated by the seemingly random fluctuation of quantitative and qualitative characteristics of cfDNA in the blood of healthy and diseased individuals. Besides methodological discrepancies, this could be ascribed to a web of cellular responses to various environmental cues and stressors. Since all cells release cfDNA, it follows that the cfDNA in the blood of cancer patients is not only representative of tumor derived DNA, but also of DNA released by healthy cells under different conditions. Additionally, cfDNA released by malignant cells is not necessarily just aberrant, but likely includes non-mutated chromosomal DNA fragments. This may cause false positive/negative results. Although many have acknowledged that this is a major problem, few have addressed it. We propose that many of the current stumbling blocks encountered in in vivo cfDNA studies can be partially circumvented by in vitro models. Accordingly, the purpose of this work was to evaluate the release of cfDNA from cultured cells and to gauge its potential use for elucidating the nature of cfDNA. Results suggest that the occurrence of cfDNA is not a consequence of apoptosis or necrosis, but primarily a result of actively secreted DNA, perhaps in association with a protein complex. This study demonstrates the potential of in vitro cell culture models to obtain useful information about the phenomenon of cfDNA.
Keywords: Apoptosis; Cell-free DNA (cfDNA); Flow cytometry; Necrosis; Osteosarcoma.
Copyright © 2015 Elsevier B.V. All rights reserved.
Similar articles
-
An Enquiry Concerning the Characteristics of Cell-Free DNA Released by Cultured Cancer Cells.Adv Exp Med Biol. 2016;924:19-24. doi: 10.1007/978-3-319-42044-8_4. Adv Exp Med Biol. 2016. PMID: 27753012
-
Characterization of the release and biological significance of cell-free DNA from breast cancer cell lines.Oncotarget. 2017 Jun 27;8(26):43180-43191. doi: 10.18632/oncotarget.17858. Oncotarget. 2017. PMID: 28574818 Free PMC article.
-
Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients.Anal Biochem. 2013 Feb 15;433(2):227-34. doi: 10.1016/j.ab.2012.06.018. Epub 2012 Jun 28. Anal Biochem. 2013. PMID: 22750103 Review.
-
Reference gene selection for in vitro cell-free DNA analysis and gene expression profiling.Clin Biochem. 2016 May;49(7-8):606-8. doi: 10.1016/j.clinbiochem.2016.01.022. Epub 2016 Feb 2. Clin Biochem. 2016. PMID: 26851157
-
The diverse origins of circulating cell-free DNA in the human body: a critical re-evaluation of the literature.Biol Rev Camb Philos Soc. 2018 Aug;93(3):1649-1683. doi: 10.1111/brv.12413. Epub 2018 Apr 14. Biol Rev Camb Philos Soc. 2018. PMID: 29654714 Review.
Cited by
-
Cell-Free DNA in the Pathogenesis and Therapy of Non-Infectious Inflammations and Tumors.Biomedicines. 2022 Nov 8;10(11):2853. doi: 10.3390/biomedicines10112853. Biomedicines. 2022. PMID: 36359370 Free PMC article. Review.
-
New Perspectives on the Importance of Cell-Free DNA Biology.Diagnostics (Basel). 2022 Sep 3;12(9):2147. doi: 10.3390/diagnostics12092147. Diagnostics (Basel). 2022. PMID: 36140548 Free PMC article. Review.
-
Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: a comparison between cell-free DNA and extracellular vesicle-derived DNA.BMC Cancer. 2018 Dec 10;18(1):1236. doi: 10.1186/s12885-018-5138-3. BMC Cancer. 2018. PMID: 30526536 Free PMC article.
-
Transcending Blood-Opportunities for Alternate Liquid Biopsies in Oncology.Cancers (Basel). 2022 Mar 3;14(5):1309. doi: 10.3390/cancers14051309. Cancers (Basel). 2022. PMID: 35267615 Free PMC article. Review.
-
The emerging role of cell-free DNA as a molecular marker for cancer management.Biomol Detect Quantif. 2019 Mar 18;17:100087. doi: 10.1016/j.bdq.2019.100087. eCollection 2019 Mar. Biomol Detect Quantif. 2019. PMID: 30923679 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources